Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Cycling and Sleep in the Pediatric ICU
NCT05003102Phase 4Withdrawn
- Sponsor
- Vanderbilt University Medical Center
- Start
- Feb 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of dexmedetomidine in sleep deprivation and delirium (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Change in total sleep time, Change in total time in different stages of sleep and 1 more. Planned start Feb 2023; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
sleep deprivationdelirium
Beyond the preview
Go deeper on NCT05003102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05003102.